<VariationArchive RecordType="classified" VariationID="40243" VariationName="NM_000138.5(FBN1):c.8155_8156del (p.Lys2719fs)" VariationType="Deletion" Accession="VCV000040243" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2019-03-04" MostRecentSubmission="2019-03-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="48727" VariationID="40243">
      <GeneList>
        <Gene Symbol="FBN1" FullName="fibrillin 1" GeneID="2200" HGNC_ID="HGNC:3603" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48408313" stop="48645709" display_start="48408313" display_stop="48645709" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48700502" stop="48937984" display_start="48700502" display_stop="48937984" Strand="-" />
          </Location>
          <OMIM>134797</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000138.5(FBN1):c.8155_8156del (p.Lys2719fs)</Name>
      <CanonicalSPDI>NC_000015.10:48412638:TT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48412639" stop="48412640" display_start="48412639" display_stop="48412640" variantLength="2" positionVCF="48412638" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48704836" stop="48704837" display_start="48704836" display_stop="48704837" variantLength="2" positionVCF="48704835" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K2719fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_778" sequenceAccession="LRG_778">
            <Expression>LRG_778:g.238149_238150del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_778t1" sequenceAccession="LRG_778t1">
            <Expression>LRG_778t1:c.8155_8156del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_778p1" sequenceAccession="LRG_778p1" change="p.Lys2719fs">
            <Expression>LRG_778p1:p.Lys2719fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.48412639_48412640del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.48412639_48412640del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.48704836_48704837del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.48704836_48704837del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008805.2" sequenceAccession="NG_008805" sequenceVersion="2" change="g.238149_238150del">
            <Expression>NG_008805.2:g.238149_238150del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000138.5" sequenceAccession="NM_000138" sequenceVersion="5" change="c.8155_8156del" MANESelect="true">
            <Expression>NM_000138.5:c.8155_8156del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000129.3" sequenceAccession="NP_000129" sequenceVersion="3" change="p.Lys2719fs">
            <Expression>NP_000129.3:p.Lys2719fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="398122831" DB="dbSNP" />
        <XRef ID="CA017581" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="134797.0064" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000138.5(FBN1):c.8155_8156del (p.Lys2719fs) AND Progeroid and marfanoid aspect-lipodystrophy syndrome" Accession="RCV000033241" Version="30">
        <ClassifiedConditionList TraitSetID="26613">
          <ClassifiedCondition DB="MedGen" ID="C4310796">Progeroid and marfanoid aspect-lipodystrophy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2010-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-03-04" MostRecentSubmission="2019-03-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20979188</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="26613" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="35310" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Progeroid and marfanoid aspect-lipodystrophy syndrome</ElementValue>
                <XRef ID="MONDO:0014831" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFANOID-PROGEROID SYNDROME</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFAN-PROGEROID-LIPODYSTROPHY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan lipodystrophy syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0066" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0064" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0065" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0069" DB="OMIM" />
                <XRef Type="Allelic variant" ID="134797.0070" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MFLS</ElementValue>
                <XRef Type="MIM" ID="616914" DB="OMIM" />
              </Symbol>
              <XRef ID="300382" DB="Orphanet" />
              <XRef ID="C4310796" DB="MedGen" />
              <XRef ID="MONDO:0014831" DB="MONDO" />
              <XRef Type="MIM" ID="616914" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="95535" SubmissionDate="2019-02-27" DateLastUpdated="2019-03-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="134797.0064_MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME" title="FBN1, 2-BP DEL, 8155AA_MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME" />
        <ClinVarAccession Accession="SCV000057097" DateUpdated="2019-03-04" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 27-year-old German woman with marfanoid-progeroid-lipodystrophy syndrome (MFLS; 616914), Graul-Neumann et al. (2010) identified heterozygosity for a de novo 2-bp deletion (8155_8156delAA) in exon 64 of the FBN1 gene, causing a frameshift that generates a premature stop codon 17 residues downstream (Lys2719AspfsTer18). The mutation was not present in either parent or in 150 unrelated controls. The patient fulfilled the clinical Ghent criteria for Marfan syndrome with 3 major features, including ectopia lentis, aortic dilatation, and dural ectasia, but also showed an extreme reduction in the amount of subcutaneous fat tissue since birth and had prominent facial lipodystrophy.</Attribute>
              <Citation>
                <ID Source="PubMed">20979188</ID>
              </Citation>
              <XRef DB="OMIM" ID="616914" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBN1" />
          </GeneList>
          <Name>FBN1, 2-BP DEL, 8155AA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 8155AA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="134797.0064" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="95535" TraitType="Disease" MappingType="Name" MappingValue="MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C4310796" Name="Progeroid and marfanoid aspect-lipodystrophy syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>